<p>The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in 0 the treatment of diseases and conditions benefiting from inverse agonism of the CB<SUB>1</SUB> and / or the CB<SUB>2</SUB> cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .</p>
